Free Trial

Intellia Therapeutics (NTLA) Earnings Date, Estimates & Call Transcripts

Intellia Therapeutics logo
$11.28 -0.32 (-2.72%)
As of 10:07 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Intellia Therapeutics Earnings Summary

Intellia Therapeutics released Q2 2025 earnings on August 7, 2025, reporting an EPS of -$0.99, which topped the consensus estimate of -$1.03 by $0.04. Quarterly revenue rose 104.3% year-over-year to $14.25 million, above analysts' expectations of $12.26 million. With a trailing EPS of -$4.69, Intellia Therapeutics' earnings are expected to grow next year, from ($5.07) to ($5.00) per share.

Upcoming Q3
Earnings Date
Nov. 6Before Market OpensEstimated
Consensus EPS
(Aug. 7)
-$1.03
Actual EPS
(Aug. 7)
-$0.99 Beat By $0.04
Actual Revenue
(Aug. 7)
$14.25M

Q2 2025 Earnings Resources

NTLA Upcoming Earnings

Intellia Therapeutics' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules.

Get Intellia Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intellia Therapeutics and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

NTLA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NTLA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Intellia Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20254-$1.40-$1.38-$1.39
Q2 20254-$1.42-$1.08-$1.27
Q3 20255-$1.62-$0.96-$1.32
Q4 20254-$1.55-$0.89-$1.29
FY 2025 17 -$5.99 -$4.31 -$5.26
Q1 20264-$1.48-$0.97-$1.24
Q2 20264-$1.48-$1.04-$1.25
Q3 20264-$1.56-$1.13-$1.38
Q4 20264-$1.67-$1.17-$1.35
FY 2026 16 -$6.19 -$4.31 -$5.22
Q1 20271-$0.97-$0.97-$0.97

Intellia Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2025
(Estimated)
--------
8/7/2025Q2 2025-$1.03-$0.99+$0.04-$0.98$12.26M$14.25M
5/8/2025Q1 2025-$1.26-$1.10+$0.16-$1.10$11.39M$16.63M
11/7/2024Q3 2024-$1.37-$1.34+$0.03-$1.34$8.28M$9.10M
8/8/2024Q2 2024-$1.23-$1.52 -$0.29-$1.10$19.68M$7.00M
5/9/2024Q1 2024-$1.35-$1.06+$0.29-$1.00$15.60M$28.94M
2/22/2024Q4 2023-$1.47-$1.46+$0.01-$1.46$15.10M-$1.92M
11/9/2023Q3 2023-$1.52-$1.38+$0.14-$1.38$12.45M$11.99M

Intellia Therapeutics Earnings - Frequently Asked Questions

Intellia Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on NTLA's earnings history.

In the previous quarter, Intellia Therapeutics (NASDAQ:NTLA) reported ($0.99) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.03) by $0.04. Learn more on analysts' earnings estimate vs. NTLA's actual earnings.

The conference call for Intellia Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Intellia Therapeutics' latest earnings report can be read online.
Read Transcript

Intellia Therapeutics (NASDAQ:NTLA) has a recorded annual revenue of $57.88 million.

Intellia Therapeutics (NASDAQ:NTLA) has a recorded net income of -$519.02 million. NTLA has generated -$4.69 earnings per share over the last four quarters.

Intellia Therapeutics' earnings are expected to grow from ($5.07) per share to ($5.00) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:NTLA) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners